• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强化急性冠状动脉综合征后降脂治疗的依从性:一项实用随机对照试验。

Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.

机构信息

1st Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Elmezzi Graduate School of Molecular Medicine and Feinstein Institutes for Medical Research at Northwell Health, Manhasset, NY, USA.

1st Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17.

DOI:10.1016/j.atherosclerosis.2021.03.013
PMID:33780749
Abstract

BACKGROUND AND AIMS

Achieving the low-density lipoprotein cholesterol (LDL-C) goal following an acute coronary syndrome (ACS) is a milestone often missed due to suboptimal adherence to secondary prevention treatments. Whether improved adherence could result in reduced LDL-C levels is unclear. We aimed to evaluate whether an educational-motivational intervention increases long-term lipid-lowering therapy (LLT) adherence and LDL-C goal attainment rate among post-ACS patients.

METHODS

IDEAL-LDL was a parallel, two-arm, single-center, pragmatic, investigator-initiated randomized controlled trial. Hospitalized patients for ACS were randomized to a physician-led integrated intervention consisting of an educational session at baseline, followed by regular motivational interviewing phone sessions or usual care. Co-primary outcomes were the LLT adherence (measured by Proportion of Days Covered (PDC); good adherence defined as PDC>80%), and LDL-C goal (<70 mg/dl or 50% reduction from baseline) achievement rate at one year.

RESULTS

In total, 360 patients (mean age 62 years, 81% male) were randomized. Overall, good adherence was positively associated with LDL-C goal achievement rate at one year. Median PDC was higher in the intervention group than the control group [0.92 (IQR, 0.82-1.00) vs. 0.86 (0.62-0.98); p = 0.03] while the intervention group had increased odds of good adherence (odds ratio: 1.76 (95% confidence interval 1.02 to 2.62; p = 0.04). However, neither the LDL-C goal achievement rate (49.6% in the intervention vs. 44.9% in the control group; p = 0.49) nor clinical outcomes differed significantly between the two groups.

CONCLUSIONS

Α multifaceted intervention improved LLT adherence in post-ACS patients without a significant difference in LDL-C goal attainment.

摘要

背景和目的

急性冠状动脉综合征(ACS)后,实现低密度脂蛋白胆固醇(LDL-C)目标是一个经常错过的里程碑,因为二级预防治疗的依从性不理想。改善依从性是否会导致 LDL-C 水平降低尚不清楚。我们旨在评估教育动机干预是否能提高 ACS 后患者的长期降脂治疗(LLT)依从性和 LDL-C 目标达标率。

方法

IDEAL-LDL 是一项平行、双臂、单中心、实用、研究者发起的随机对照试验。因 ACS 住院的患者被随机分配到以医生为主导的综合干预组,该干预组在基线时进行一次教育课程,然后定期进行动机访谈电话会话或常规护理。主要结局是 LLT 依从性(通过用药天数比例(PDC)衡量;定义为 PDC>80%为良好依从性)和 LDL-C 目标(<70mg/dl 或比基线降低 50%)在一年时的达标率。

结果

共 360 例患者(平均年龄 62 岁,81%为男性)被随机分配。总体而言,良好的依从性与 LDL-C 目标在一年时的达标率呈正相关。干预组的 PDC 中位数高于对照组[0.92(IQR,0.82-1.00)比 0.86(0.62-0.98);p=0.03],而干预组的良好依从性的可能性更高(比值比:1.76(95%置信区间 1.02 至 2.62;p=0.04)。然而,两组之间 LDL-C 目标达标率(干预组为 49.6%,对照组为 44.9%;p=0.49)或临床结局均无显著差异。

结论

多方面的干预措施提高了 ACS 后患者的 LLT 依从性,但 LDL-C 目标达标率无显著差异。

相似文献

1
Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.强化急性冠状动脉综合征后降脂治疗的依从性:一项实用随机对照试验。
Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17.
2
Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.旨在支持急性冠状动脉综合征(IDEAL-LDL)患者 LDL-C 治疗目标和降脂治疗依从性的动机性访谈研究:原理和设计。
Hellenic J Cardiol. 2019 Jul-Aug;60(4):249-253. doi: 10.1016/j.hjc.2018.10.002. Epub 2018 Oct 21.
3
Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.法国冠心病患者低密度脂蛋白胆固醇目标未达最佳水平。来自DYSIS II ACS/CHD研究的当代数据。
Arch Cardiovasc Dis. 2017 Mar;110(3):167-178. doi: 10.1016/j.acvd.2016.11.004. Epub 2017 Feb 13.
4
Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.降脂治疗与急性冠状动脉综合征后 LDL-C 目标达标:一项丹麦基于人群的队列研究。
BMC Cardiovasc Disord. 2020 Jul 13;20(1):336. doi: 10.1186/s12872-020-01616-9.
5
Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.稳定性或急性冠心病患者的胆固醇目标值达标和降脂治疗:来自血脂异常国际研究 II 的结果。
Atherosclerosis. 2017 Nov;266:158-166. doi: 10.1016/j.atherosclerosis.2017.08.013. Epub 2017 Aug 21.
6
Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China.急性冠状动脉综合征后糖尿病患者的血脂达标情况:血脂异常国际研究 II-中国的亚组分析。
BMC Cardiovasc Disord. 2023 Jul 1;23(1):337. doi: 10.1186/s12872-023-03312-w.
7
Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.中国急性冠脉综合征后患者的血脂达标情况:来自真实世界血脂异常国际研究 II 的 6 个月结果。
Clin Cardiol. 2021 Nov;44(11):1575-1585. doi: 10.1002/clc.23725. Epub 2021 Oct 15.
8
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.急性和慢性冠心病患者 LDL-胆固醇靶值达标情况的预测因素不同:来自 DYSIS II Europe 的结果。
Eur J Prev Cardiol. 2018 Dec;25(18):1966-1976. doi: 10.1177/2047487318806359. Epub 2018 Oct 18.
9
Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II.泰国急性冠状动脉综合征存活患者的低密度脂蛋白胆固醇目标达标情况:血脂异常国际研究(DYSIS II)的结果。
Heart Lung Circ. 2020 Mar;29(3):405-413. doi: 10.1016/j.hlc.2019.02.193. Epub 2019 Mar 28.
10
Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.多方面干预措施改善急性冠状动脉综合征出院后患者的用药依从性和二级预防措施:一项随机临床试验。
JAMA Intern Med. 2014 Feb 1;174(2):186-93. doi: 10.1001/jamainternmed.2013.12944.

引用本文的文献

1
Learnings from Implementation Strategies to Improve Lipid Management.从改善血脂管理的实施策略中获得的经验教训。
Curr Cardiol Rep. 2025 Jan 8;27(1):9. doi: 10.1007/s11886-024-02174-8.
2
Effectiveness of treat-to-target cholesterol-lowering interventions on cardiovascular disease and all-cause mortality risk in the community-dwelling population: a target trial emulation.基于目标值的降脂干预对社区居民心血管疾病和全因死亡率风险的有效性:一项目标试验模拟研究。
Nat Commun. 2024 Nov 15;15(1):9922. doi: 10.1038/s41467-024-54078-4.
3
Improving transitional care after acute myocardial infarction: A scoping review.
改善急性心肌梗死后的过渡性护理:一项范围综述。
Health Care Sci. 2024 Oct 13;3(5):312-328. doi: 10.1002/hcs2.116. eCollection 2024 Oct.
4
Association between medication adherence and health-related quality of life of patients with hypertension and dyslipidemia.高血压和血脂异常患者的药物依从性与健康相关生活质量之间的关联。
Hormones (Athens). 2023 Dec;22(4):665-676. doi: 10.1007/s42000-023-00471-5. Epub 2023 Jul 26.
5
Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia.沙特阿拉伯急性冠状动脉综合征患者血脂管理的前瞻性评估。
Saudi Med J. 2023 Jun;44(6):570-579. doi: 10.15537/smj.2023.44.6.20230023.
6
Intensive nurse-led follow-up in primary care to improve self-management and compliance behaviour after myocardial infarction.强化以护士为主导的初级保健随访,以改善心肌梗死后的自我管理和依从性行为。
Nurs Open. 2023 Aug;10(8):5211-5224. doi: 10.1002/nop2.1758. Epub 2023 Apr 21.
7
DNA Methylation Aberrant in Atherosclerosis.动脉粥样硬化中的DNA甲基化异常
Front Pharmacol. 2022 Mar 3;13:815977. doi: 10.3389/fphar.2022.815977. eCollection 2022.
8
Associations of statin adherence and lipid targets with adverse outcomes in myocardial infarction survivors: a retrospective cohort study.他汀类药物依从性和血脂目标与心肌梗死幸存者不良结局的关联:一项回顾性队列研究。
BMJ Open. 2021 Sep 27;11(9):e054893. doi: 10.1136/bmjopen-2021-054893.